Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4295605 Target Snapshot

Inosine-5'-monophosphate dehydrogenase · SINGLE PROTEIN · Cryptococcus neoformans var. neoformans serotype D (strain JEC21 /ATCC MYA-565) (Filobasidiella neoformans)

16Compounds
38Assays
1Approved Drugs
16.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q5KP44. Use UniProt Q5KP44 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q5KP44 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Inosine-5'-monophosphate dehydrogenase as ChEMBL target CHEMBL4295605, mapped to UniProt Q5KP44. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Inosine-5'-monophosphate dehydrogenase
SINGLE PROTEIN · Cryptococcus neoformans var. neoformans serotype D (strain JEC21 /ATCC MYA-565) (Filobasidiella neoformans)
As of 2026-09-14
ChEMBL target ID
CHEMBL4295605
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q5KP44
Inosine-5'-monophosphate dehydrogenase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Inosine-5'-monophosphate dehydrogenase is the right protein anchor across sources, using UniProt Q5KP44 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelInosine-5'-monophosphate dehydrogenase
UniProt AccessionQ5KP44
Component TypeProtein
Sequence Length544 aa

Inosine-5'-monophosphate dehydrogenase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Inosine-5'-monophosphate dehydrogenase, mapped to UniProt Q5KP44. Sequence length is 544 aa.

Mapped IDQ5KP44
Review nameInosine-5'-monophosphate dehydrogenase
OrganismCryptococcus neoformans var. neoformans serotype D (strain JEC21 /ATCC MYA-565) (Filobasidiella neoformans)
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5016.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL866 6.92 IC50 120.0 Approved
CHEMBL4277486 6.82 IC50 150.0 Preclinical
CHEMBL4289187 6.8 IC50 160.0 Preclinical
CHEMBL4288538 6.64 IC50 230.0 Preclinical
CHEMBL4277233 6.47 IC50 340.0 Preclinical
CHEMBL1602759 6.43 IC50 370.0 Preclinical
CHEMBL4280641 6.4 IC50 400.0 Preclinical
CHEMBL4176498 6.39 IC50 410.0 Preclinical
CHEMBL4284098 6.32 IC50 480.0 Preclinical
CHEMBL4166303 6.31 IC50 490.0 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
2
5.5
10
6.0
4
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

MYCOPHENOLIC ACID
CHEMBL866
Approved 2004
Assay Landscape

Assay Landscape

38
Total Assays
16
Tested Compounds
1
Assay Types
Binding — 38 assays, 16 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 38 16 6.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine